Rubicon Organics Stock Price To Earning
ROMJ Stock | CAD 0.30 0.06 16.67% |
Rubicon Organics fundamentals help investors to digest information that contributes to Rubicon Organics' financial success or failures. It also enables traders to predict the movement of Rubicon Stock. The fundamental analysis module provides a way to measure Rubicon Organics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rubicon Organics stock.
Rubicon | Price To Earning |
Rubicon Organics Company Price To Earning Analysis
Rubicon Organics' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Rubicon Price To Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for Rubicon Organics is extremely important. It helps to project a fair market value of Rubicon Stock properly, considering its historical fundamentals such as Price To Earning. Since Rubicon Organics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Rubicon Organics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Rubicon Organics' interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition |
Rubicon Retained Earnings
Retained Earnings |
|
Based on the latest financial disclosure, Rubicon Organics has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The price to earning for all Canada stocks is 100.0% higher than that of the company.
Rubicon Organics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Rubicon Organics from analyzing Rubicon Organics' financial statements. These drivers represent accounts that assess Rubicon Organics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Rubicon Organics' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 69.8M | 158.9M | 101.6M | 43.3M | 49.8M | 47.3M | |
Enterprise Value | 81.0M | 160.7M | 99.8M | 45.2M | 52.0M | 49.4M |
Rubicon Fundamentals
Return On Equity | -0.0933 | ||||
Return On Asset | -0.025 | ||||
Profit Margin | (0.08) % | ||||
Operating Margin | 0.01 % | ||||
Current Valuation | 18 M | ||||
Shares Outstanding | 56.21 M | ||||
Shares Owned By Insiders | 53.51 % | ||||
Shares Owned By Institutions | 3.88 % | ||||
Number Of Shares Shorted | 9 | ||||
Price To Book | 0.45 X | ||||
Price To Sales | 0.40 X | ||||
Revenue | 41.12 M | ||||
Gross Profit | 1.51 M | ||||
EBITDA | 845.83 K | ||||
Net Income | (5.49 M) | ||||
Cash And Equivalents | 4.22 M | ||||
Cash Per Share | 0.08 X | ||||
Total Debt | 758.46 K | ||||
Debt To Equity | 0.22 % | ||||
Current Ratio | 6.35 X | ||||
Book Value Per Share | 0.67 X | ||||
Cash Flow From Operations | 6.79 M | ||||
Earnings Per Share | (0.07) X | ||||
Target Price | 1.1 | ||||
Number Of Employees | 180 | ||||
Beta | 1.12 | ||||
Market Capitalization | 16.58 M | ||||
Total Asset | 56.11 M | ||||
Retained Earnings | (89.7 M) | ||||
Working Capital | 19.32 M | ||||
Net Asset | 56.11 M |
About Rubicon Organics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rubicon Organics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rubicon Organics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rubicon Organics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Rubicon Stock Analysis
When running Rubicon Organics' price analysis, check to measure Rubicon Organics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rubicon Organics is operating at the current time. Most of Rubicon Organics' value examination focuses on studying past and present price action to predict the probability of Rubicon Organics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rubicon Organics' price. Additionally, you may evaluate how the addition of Rubicon Organics to your portfolios can decrease your overall portfolio volatility.